Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Valencia
Clinical trial register · Spain

Clinical Trials in Valencia, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 56 Madrid 54 Valencia 21 Málaga 19 Santander 14
Narrow the registerReset
Recruitment status
Phase
Site location
Barcelona56 Madrid54 Valencia21 Málaga19 Santander14
All 70 locations
Target enrolment
to

Trials with a site in Valencia

21 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
GlaxoSmithKline
Phase 3
450
Barcelona, Madrid, Oviedo, Seville, Valencia, Zaragoza
2025-12-03
Recruiting
GlaxoSmithKline
Phase 2
363
Barcelona, Lleida, Madrid, MErida Badajoz, Oviedo, Valencia
2025-10-30
Recruiting
GlaxoSmithKline
Phase 2
80
Barcelona, Madrid, Málaga, Ourense, PamplonaNavarra, Salamanca, Valencia
2025-06-05
Active, closed
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
NCT06521567Melanoma, Hodgkin Lymphoma, High and Low Grade Glioma, Glioblastoma Multiforme (GBM)
GlaxoSmithKline
Phase 1/2
83
Barcelona, Madrid, Valencia
2025-03-06
Recruiting
GlaxoSmithKline
Phase 1/2
305
A Coruña, Barcelona, Madrid, Málaga, Valencia, Zaragoza
2025-03-04
Recruiting
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
NCT06517875Primary Myelofibrosis, Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis
GlaxoSmithKline
Phase 2
68
Badalona, Barcelona, Las Palmas, Madrid, Málaga, Valencia
2025-02-28
Active, closed
GlaxoSmithKline
Phase 2
283
Barcelona, León, Madrid, Salamanca, Santander, Valencia
2024-11-11
Recruiting
GlaxoSmithKline
Phase 1
845
Badajoz, Barcelona, Madrid, Málaga, Valencia, Zaragoza
2024-09-30
Recruiting
GlaxoSmithKline
Phase 2
393
Barcelona, León, Madrid, Santander, Seville, Valencia, Valladolid, Vigo
2024-09-27
Active, closed
GlaxoSmithKline
Phase 3
10,212
Santiago de Compostela, Centelles, Vic, Majadahonda, Alcorcón, Barcelona, Madrid, Valencia
2024-08-01
Active, closed
GlaxoSmithKline
Phase 4
336
Barcelona, Girona, Valencia
2024-03-20
Active, closed
GlaxoSmithKline
Phase 2
316
Barcelona, Jaén, Madrid, Pozuelo de AlarcOn Madr, Salamanca, Santander, Valencia, Zaragoza
2023-11-14
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
NCT05878717Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
GlaxoSmithKline
Phase 2/3
300
Barcelona, Bilbao, Granada, Madrid, Seville, Valencia, VigoPontevedra
2023-09-13
Active, closed
GlaxoSmithKline
Phase 2
154
Barcelona, Granada, Madrid, Santander, Valencia
2023-04-03
Active, closed
GlaxoSmithKline
Phase 2
351
Badajoz, Badalona, Barcelona, Las Palmas de Gran Canar, Madrid, Málaga, PamplonaNavarra, Valencia
2022-10-14
Recruiting
GlaxoSmithKline
Phase 3
109
Barcelona, Granada, Madrid, Pozuelo de AlarcOn Madr, Salamanca, Valencia, Zaragoza
2022-09-06
Active, closed
GlaxoSmithKline
Phase 2
360
HebrOn, León, Madrid, Santander, Valencia, Vigo
2021-12-14
Active, closed
GlaxoSmithKline
Phase 3
40
Barcelona, Cáceres, Córdoba, Granada, Madrid, Málaga, Santiago de Compostela, Valencia
2021-06-28
Active, closed
GlaxoSmithKline
Phase 3
242
Barcelona, Madrid, Seville, Valencia
2020-07-14
Active, closed
GlaxoSmithKline
Phase 2
25
Barcelona, Madrid, Valencia
2019-11-28
Rows per page Showing 1–21 of 21
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/valencia

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 21 of those studies with a site in Valencia that also match the filters currently applied.

How many clinical trials are recruiting in Valencia?

10 of the 21 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 11 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Valencia), 21 studies
PhaseStudiesRecruitingShare
Phase 211552.4%
Phase 35223.8%
Phase 1/2219.5%
Phase 1114.8%
Phase 2/3114.8%
Phase 4104.8%

Most active sponsors

Lead sponsors with the most studies (Valencia)
Lead sponsorStudiesRecruiting
GlaxoSmithKline2110
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.